Singapore markets close in 6 hours 49 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
105.39-1.57 (-1.47%)
At close: 04:03PM EST
105.15 -0.24 (-0.23%)
After hours: 06:23PM EST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
7,889,000
7,071,000
4,495,000
3,687,000
2,368,000
Depreciation & amortisation
3,343,000
3,538,000
3,327,000
3,014,000
3,278,000
Stock-based compensation
676,000
640,000
546,000
519,000
477,000
Change in working capital
-1,739,000
-771,000
-892,000
-1,331,000
-148,000
Accounts receivable
-598,000
-383,000
-924,000
-275,000
-190,000
Inventory
-1,209,000
-456,000
-493,000
-593,000
-514,000
Accounts payable
-
1,288,000
1,766,000
220,000
747,000
Other working capital
8,541,000
8,648,000
5,724,000
4,498,000
4,906,000
Other non-cash items
-
-
-
-
32,000
Net cash provided by operating activities
10,322,000
10,533,000
7,901,000
6,136,000
6,300,000
Cash flows from investing activities
Investments in property, plant and equipment
-1,781,000
-1,885,000
-2,177,000
-1,638,000
-1,394,000
Acquisitions, net
0
-187,000
-42,000
-170,000
0
Purchases of investments
-
-173,000
-83,000
-103,000
-131,000
Sales/maturities of investments
-
77,000
10,000
21,000
73,000
Other investing activities
26,000
26,000
19,000
27,000
48,000
Net cash used for investing activities
-1,779,000
-2,008,000
-2,215,000
-1,815,000
-1,356,000
Cash flows from financing activities
Debt repayment
-756,000
-48,000
-1,333,000
-3,441,000
-12,433,000
Common stock repurchased
-4,084,000
-2,299,000
-403,000
-718,000
-238,000
Dividends paid
-3,284,000
-3,202,000
-2,560,000
-2,270,000
-1,974,000
Other financing activities
-
-
-11,000
-
-
Net cash used provided by (used for) financing activities
-8,065,000
-5,494,000
-2,779,000
-4,289,000
-10,391,000
Net change in cash
292,000
2,961,000
2,978,000
16,000
-5,563,000
Cash at beginning of period
9,302,000
6,838,000
3,860,000
3,844,000
9,407,000
Cash at end of period
9,780,000
9,799,000
6,838,000
3,860,000
3,844,000
Free cash flow
Operating cash flow
10,322,000
10,533,000
7,901,000
6,136,000
6,300,000
Capital expenditure
-1,781,000
-1,885,000
-2,177,000
-1,638,000
-1,394,000
Free cash flow
8,541,000
8,648,000
5,724,000
4,498,000
4,906,000